TEVA icon

Teva Pharmaceuticals

427 hedge funds and large institutions have $4.07B invested in Teva Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 119 increasing their positions, 145 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
427
Holders Change
-25
Holders Change %
-5.53%
% of All Funds
9.38%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.07%
New
46
Increased
119
Reduced
145
Closed
69
Calls
$219M
Puts
$385M
Net Calls
-$166M
Net Calls Change
-$112M
Name Holding Trade Value Shares
Change
Shares
Change %
PFO
351
Pathstone Family Office
New Jersey
$4K
AA
352
Advisory Alpha
Michigan
$3.92K +$3.92K +600 New
BCWM
353
Bartlett & Co Wealth Management
Ohio
$3.89K
EW
354
Evoke Wealth
California
$3.4K +$3.4K +494 New
OC
355
Oakworth Capital
Alabama
$3K -$18.5K -3,200 -86%
EFSCE
356
Enterprise Financial Services Corp (EFSC)
Missouri
$3K
ATC
357
Adirondack Trust Company
New York
$3K
FANJ
358
Financial Architects (New Jersey)
New Jersey
$3K
PFBT
359
Parkside Financial Bank & Trust
Missouri
$3K
WCG
360
Weaver Consulting Group
California
$3K
RFA
361
Reilly Financial Advisors
California
$3K
SCA
362
Stonebridge Capital Advisors
Minnesota
$3K
TCM
363
Tradewinds Capital Management
Washington
$3K
VNA
364
Valley National Advisers
Pennsylvania
$3K +$616 +100 +26%
SWM
365
Selective Wealth Management
Virginia
$3K +$3K +425 New
NCM
366
Nelson Capital Management
California
$3K +$3K +471 New
IA
367
IFP Advisors
Florida
$3K +$3K +616 New
WPW
368
Winthrop Partners - WNY
New York
$2.75K
RCAG
369
Rehmann Capital Advisory Group
Michigan
$2.44K +$337 +49 +16%
ZB
370
Zions Bancorporation
Utah
$2K -$977 -130 -33%
WAP
371
Wealthcare Advisory Partners
Pennsylvania
$2K -$332 -50 -14%
BFC
372
Bedel Financial Consulting
Indiana
$2K
APSP
373
Asset Planning Services (Pennsylvania)
Pennsylvania
$2K
AF
374
Allworth Financial
California
$2K
BRC
375
Bell Rock Capital
Delaware
$2K